Trial · NCT07908472
Sarcopenia and Training Outcomes in Post-cardiac Surgery Patients
NCT07908472, Recruiting, Universitaire Ziekenhuizen KU Leuven
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Sarcopenia and Training Outcomes in Post-cardiac Surgery Patients. Trials, record NCT07908472. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07908472
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Sarcopenia and Training Outcomes in Post-cardiac Surgery Patients
- NCT number
- NCT07908472
- Status
- Recruiting
- Enrollment
- 300 participants, estimated
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Conditions
- Sarcopenia, Cardiac Surgery
- Interventions
- No intervention (observational study)
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of patients with sarcopenia at different stages of rehabilitation after cardiac surgery as assessed by EWGSOP2-criteria | 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in. | The EWGSOP-criteria offer an algorithm for case finding, diagnosing and quantifying severity of sarcopenia. The SARC-F questionnaire is used to find cases. Muscle strength is tested to assess sarcopenia. Muscle quantity is assessed to confirm sarcopenia, and lastly, functional tests are used to determine the severity of sarcopenia. All criteria are included below. |
| Primary | Screening for the presence of sarcopenia by the SARC-F questionnaire | 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in. | SARC-F stands for Strength, Assistance in walking, Rise from a chair, Climb stairs, Falls. It can have a score between 0 and 10, with a score of 4 or more indicating the patient should receive deeper diagnostic screening. |
| Primary | Handgrip strength assessed with a handheld dynamometer | 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in. | A handgrip strength in the dominant hand of \<27kg for men and \<16kg for women indicates the possible presence of sarcopenia. |
| Primary | Lower body strength assessed by the 5x sit-to-stand test | 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in. | A 5x sit-to-stand test \>15 seconds for both sexes indicates the possible presence of sarcopenia. |
| Primary | Muscle quantity assessed by bio-electrical impedance (InBody 770s) | 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in. | A muscle quantity of \<20kg for men and \<15kg for women confirms sarcopenia. |
| Primary | Severity of sarcopenia assessed by short physical performance battery | 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in. | A score of 8 or less on the SPPB indicates severe sarcopenia. |
| Primary | Severity of sarcopenia assessed by 4m walking speed | 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in. | A gait speed of 0.8m/s or less indicates severe sarcopenia. |
| Primary | Severity of sarcopenia assessed by timed up-and-go test | 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in. | A TUG of 20 seconds or more indicates severe sarcopenia. |
| Secondary | Medical history assessed from the patient medical record | At baseline | Type of cardiac surgery, date of cardiac surgery, comorbidities |
| Secondary | Medication assessed from the patient medical record | 1 to 4 times (baseline, 4 weeks after surgery, 16 weeks after surgery, 1-year after surgery) during the follow-up period, depending on the cohort the patient is in. | Cardiovascular medication, anticoagulans, antidiabetic, lipid lowering, antiarrhythmic, other. All medications will be recorded as class of medication, generic name, brand name, dosage, and frequency |
1 to 10 of 17Source ClinicalTrials.gov
See all 17 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07908472
GET https://conductscience.org/api/trials/v1/NCT07908472/registered